6
Participants
Start Date
May 1, 2021
Primary Completion Date
December 31, 2022
Study Completion Date
June 30, 2023
Incobotulinumtoxin A (BTX A) Xeomin®
Injections into the masseter muscles bilaterally (25 Units per muscle applied with 2 injections in each muscle)
University of Zurich, Center of Dental Medicine, Zurich
Collaborators (1)
Merz Pharmaceuticals
INDUSTRY
Dominik Ettlin
OTHER